CLOSEAP+Système de délivrance d'insuline en boucle fermée et service de fournisseur de soins de santé à domicile pour le diabète de type 2 non contrôlé

This study focuses on a special insulin delivery system called a 'closed-loop insulin delivery system' or 'Artificial Pancreas (AP)'. The aim is to help people with Type 2 Diabetes who have poor control over their condition, especially those who need home nursing care for their daily insulin treatment. The study seeks to understand if this system, when combined with personalized home healthcare services, can improve blood sugar control, lower the risk of complications, enhance patients' quality of life, and reduce healthcare costs compared to usual care. Participants in this study will use the Artificial Pancreas system at home for a certain period. The main goal is to measure the 'Time in Range' (TIR), which is the percentage of time the blood sugar level stays within a healthy range (70-180 mg/dL or 3.9-10.0 mmol/L). This will be tracked using a continuous glucose monitoring system during the last 14 days of the study, from days 70 to 90.